Krystal Biotech Inc expected to post earnings of 15 cents a share - Earnings Preview

Krystal Biotech

03/05/2024 17:09

* Krystal Biotech Inc  KRYS.OQ   KRYS.O  is expected to show
a
rise in quarterly revenue when it reports  results on May 6 for
the period ending March 31 2024
    * The Pittsburgh Pennsylvania-based  company is expected to
report
revenue of $47.42 million, according to the mean estimate from 8
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Krystal Biotech Inc is
for
earnings of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 4.6%
in the last three months. ​
    * Wall Street's median 12-month price target for Krystal
Biotech
Inc is $197.50​, above​ its last closing price of $160.23. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.42       -0.42      0.30      Beat    170.6
 Sep. 30 2023  -0.32       -0.29      -0.69     Missed  -141.3
 Jun. 30 2023  -0.69       -0.74      -1.25     Missed  -69.7​
 Mar. 31 2023  -1.43       -1.44      -1.76     Missed  -22.3
 ​​Dec.        -1.31       -1.32      -1.25     Beat    5.4
 31 2022                                                
 Sep. 30 2022  -1.23                  -1.17             3.9​
 Jan. 1 0001   -0.99       -1.02      -1.10     Missed  -8.3
 Mar. 31 2022  -1.06       -1.05      -0.99     Beat    5.6
 This summary was machine generated May 3 at 16:09 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)